Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 561 of 6351
-
New hope for painful skin condition: drug trial targets stubborn HS
Disease control Recruiting nowThis is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Phase 2/3 • Sponsor: Bluefin Biomedicine, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo targets Hard-to-Treat stomach cancer in early trial
Disease control Recruiting nowThis is a phase 2 study designed to evaluate the safety and efficacy of IBI363 in combination with oxaliplatin and capecitabine (XELOX) or S-1 and oxaliplatin (SOX) in perioprative treatment of locally advanced MHC-II-negative gastric and gastroesophageal junction adenocarcinoma.
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New alpha radiation therapy shows promise for tough prostate cancer
Disease control OngoingThis Phase 1 study will evaluate the safety, tolerability, and preliminary effectiveness of AB001, an alpha-emitting radioligand targeting prostate-specific membrane antigen (PSMA), in patients with advanced prostate cancer who are either 177Lu-PSMA naïve or experienced. The stud…
Phase 1 • Sponsor: ARTBIO Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for stroke patients: drug may work even after 4.5 hours
Disease control Recruiting nowThe CHESTNUT trial is a multicenter, open-label, blinded-endpoint, randomized, controlled, phase 3 trial. The primary objective of this study is to explore the efficacy and safety of the dose of 0.25 mg/kg tenecteplase (TNK) in Chinese acute ischemic stroke (AIS) patients without…
Phase 3 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could some esophageal cancer patients skip surgery? new trial tests a less invasive option
Disease control Recruiting nowThis is a multi-center, Phase II clinical study aiming to evaluate the efficacy, safety, and organ preservation feasibility of definitive concurrent chemoradiotherapy versus surgery in patients with locally advanced resectable esophageal squamous cell carcinoma (ESCC) who achieve…
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Stenting silent heart plaques may save lives: major trial underway
Disease control Recruiting nowThe aim of this clinical trial is to explore the optimal preventative treatment strategy for non-flow-limiting vulnerable plaques. The main question it aims to answer is: Can interventional therapy further improve the outcome of non-flow-limiting vulnerable plaques on top of opt…
Phase 4 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can a higher starting dose of thyroid hormone speed up recovery in newborns?
Disease control CompletedThis randomized controlled trial compared high-dose and moderate-dose levothyroxine as initial therapy for neonates with primary congenital hypothyroidism. One hundred one infants were randomized to receive either approximately 12.85 or 7.65 µg/kg/day. Thyroid function and dose a…
Phase 4 • Sponsor: Menoufia University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Promising cocktail of drugs aims to wipe out esophageal tumors before surgery
Disease control By invitation onlyWe plan to conduct a single-center,prospective, Open Label, Randomized Controlled, Phase II Clinical Study of the Combination of Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Phase 2 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New study aims to keep opioid patients on recovery track after ER visit
Disease control Recruiting nowThe main purpose of this stepped wedge trial will be to test the impact of a bundle of implementation strategies designed to improve ED-outpatient care coordination on long-term buprenorphine retention among adult patients who start buprenorphine for opioid use disorder in a hosp…
Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Immune cell therapy GT201 targets advanced tumors in early trial
Disease control Recruiting nowThis is a multicenter Phase I/II clinical trial. It aims to evaluate the safety, tolerability, efficacy and pharmacokinetics (PK) of GT201 in patients with advanced solid tumors.
Phase 1/2 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Brain surgery gets a GPS: new trial aims to save speech and movement
Disease control Recruiting nowThis study is designed for patients with brain tumors located in eloquent brain areas involved in language, motor, or major functional brain networks. The purpose of the study is to determine whether connectome-guided navigation-assisted microsurgical resection can better preserv…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a gentler chemo combo with delayed immunotherapy tame advanced lung cancer?
Disease control Recruiting nowThis study is a multicenter randomized controlled clinical trial targeting subjects with advanced or metastatic squamous NSCLC with unknown or negative gene status, aiming to evaluate the efficacy and safety of first-line delayed administration of Serplulimab combined with a low-…
Early phase 1 • Sponsor: People's Hospital of Quzhou • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New fertility drug aims to boost IVF live birth rates
Disease control Recruiting nowThe goal of this multicenter, randomized, placebo-controlled, double-blind clinical trial is toto evaluate the efficacy and safety of a human menopausal gonadotropin (hMG) in the development of multiple follicles, pregnancy, and cumulative live birth as part of an Assisted Reprod…
Phase 3 • Sponsor: Granata Bio Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could a breath test reveal Parkinson's risk?
Knowledge-focused Recruiting nowGut problems, such as constipation, can have an important impact on quality of life of people who have them, and have been associated with higher risk of developing neurological diseases such as Parkinson's or Alzheimer's disease. Recent studies suggest that gut problems may als…
Sponsor: University of Cambridge • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Bone marrow injection into skull shows promise for severe stroke recovery
Disease control Not yet recruitingAn open-label, blinded phase II study investigating the treatment of acute large hemispheric infarction by transcranial bone marrow injection of RK-4 injection For subjects with acute large hemispheric infarction who are contraindicated to vascular recanalization or have poor res…
Phase 2 • Sponsor: Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
AI heart scanner aims to catch silent AFib before it strikes
Diagnosis Not yet recruiting"The DEEP-AF study is a prospective, multi-center, randomized clinical trial evaluating the effectiveness of an artificial intelligence-enhanced electrocardiography algorithm (SmartECG-AFrisk) for early detection of atrial fibrillation (AF) in adults with suspected AF but no prio…
Sponsor: Yonsei University • Aim: Diagnosis
Last updated Jun 26, 2026 17:01 UTC
-
New drug aims to stop skin lymphoma from returning after transplant
Disease control Not yet recruitingAllogeneic hematopoietic stem cell transplantation (alloHSCT) showed efficacy in advanced-stage, high-risk, treatment sensitive cutaneous T-cell lymphomas (CTCL) in a prospective, propensity score-matched controlled study (CUTALLO) published by our group in the Lancet in 2023. Ne…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC
-
Could immune cells from your own body help you carry a baby?
Disease control Not yet recruitingThe aim of this study is to verify the efficacy of in vitro induction of autologous decidual-like NK cells therapy for reproductive failure associated with uterine NK cells abnormalities.
Phase 2 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Supercharged immune cells take on tough lupus cases
Disease control Recruiting nowThis is an investigator-initiated trial aimed at assessing the safety and efficacy of ultra-fast autologous CD19-targeted CAR-T cells in the treatment of refractory systemic lupus erythematosus.
Phase 1 • Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Eye scan could spot Parkinson's years before symptoms worsen
Diagnosis Recruiting nowThe objective of this observational study is to investigate whether non-invasive fundus retinal detection technology can be used for the early diagnosis of parkinson's disease (PD). It aims to answer the following primary questions: the sensitivity and specificity of non-invasive…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC